US FDA Says White Paper Could Inform Rulemaking For Cosmetic Talc-Asbestos Testing
Executive Summary
Formed by the FDA in fall 2018 and convened in early 2020 for a public meeting, the Interagency Working Group on Asbestos in Consumer Products maintains that electron microscopy should be a first-line method for detecting asbestos in cosmetic talc and talc-containing products, and that labs should report elongate mineral particles beyond those classically understood as asbestos.
You may also be interested in...
Compliance Clock Starts Ticking Under Historic Modernization of Cosmetic Regulations Act
Companies have one year to comply with US FDA registration and product listing requirements under the Modernization of Cosmetic Regulations Act of 2022, part of the $1.7tr omnibus spending package signed by President Joe Biden on 29 December. Trade groups applauded the historic milestone and the legislation’s departure from previous proposals, including the elimination of user fees.
US FDA Again Finds Talc-Containing Cosmetics Asbestos-Free In 2022 Testing
No asbestos was detected in product samples from brands including Lancome Paris, Clinique, Gucci, Avon, and Neutrogena, the FDA says. Like in 2021, the agency’s 2022 testing provides assurances after 17% of talc-containing cosmetic products analyzed in 2019 were found to be tainted with asbestos.
US FDA Cosmetics Director Lists Talc, Formaldehyde In Hair Smoothers Among Priorities
Linda Katz, director of the FDA’s Office of Cosmetics and Colors, touched on cosmetics modernization legislation in her 21 September presentation on agency priorities at the Independent Beauty Association’s virtual FDA Cosmetics Regulations Workshop.